物理化学纳米封装和微流体驱动基因和瘤微环境调制
Ana Belen Peñaherrera-Pazmiño1, Mishell Criollo1, Rebeca Gonzalez-Pastor1
1Centro de Investigación Biomédica (CENBIO), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Frontiers in pharmacology
|October 15, 2025
概括
植物化学物质显示出抗癌承诺,但面临着交付挑战. 纳米封装和微流体改善了它们在癌症治疗中的有效性和安全性,克服了溶解性差和瘤透.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 植物化学物质具有抗癌性质,但其生物利用性较差,瘤向性有限.
- 纳米封装增强了植物化学稳定性,溶解性和向性输送,改善治疗结果并减少毒性.
研究的目的:
- 审查用于癌症治疗的纳米尺度植物化学递送系统的最新进展.
- 突出微流体在制造和评估这些纳米载体中的作用.
主要方法:
- 基于脂质的,聚合物的,混合的和生物的纳米载体的审查,用于植物化学物质的输送.
- 讨论微流体平台用于精确的纳米载体制造和生物仿真测试.
主要成果:
- 纳米尺度的输送系统,包括基于脂质和聚合物纳米载体,改善了植物化学物质的生物分布和细胞吸收.
- 微流体学使植物化学纳米载体的可重复制造和生物模拟模型的先进临床前测试成为可能.
结论:
- 纳米技术和微流体的整合为开发有效和安全的植物化学基癌症疗法提供了有前途的战略.
- 需要进一步的研究来应对扩大规模,标准化和全面的药理动力学/毒理学数据方面的挑战.
相关概念视频
Microorganisms in Medicine and Therapeutics
960
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
960
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K


